Corporate VC activity in medtech increases – until this year
In 2018 more than a quarter of medtech funding came from rounds in which corporate VCs took part.
Auris acquisition could prompt more mega VC rounds
The J&J-Auris tie-up will yield a huge return for investors who went in big.
J&J’s Auris buy looks like a Verb swerve
Johnson & Johnson’s $3.4bn move for the robotic surgery specialist Auris Health could be bad news for its Verb Surgical joint venture.
Fewer than 200 medtech VC rounds closed in 2018
Investors swerve traditional medical devices in favour of artificial intelligence-enabled diagnostics.
Medtech funding ventures into the unknown
In a truly extraordinary year, the top 10 venture rounds made up more than half of the total invested.
Medtech VC enters a gilded age – but with even less cash for series As
Vast amounts of venture cash are available to medical device makers, but its distribution is uneven.
Medtech venture funding total hits all-time high
So far, 2017 has been a record-breaker in a number of ways – and none of them bode well for start-ups.
Kickstarting ideas
Independent, data-driven daily news and analysis on pharma, biotech and medtech.